{"id":"https://openalex.org/W7225730078","doi":"https://doi.org/10.25251/sdy32180","title":"GPP OBSERVE: Real-world clinical characteristics and treatment patterns among patients with generalized pustular psoriasis in the United States","display_name":"GPP OBSERVE: Real-world clinical characteristics and treatment patterns among patients with generalized pustular psoriasis in the United States","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225730078","doi":"https://doi.org/10.25251/sdy32180"},"language":"en","primary_location":{"id":"doi:10.25251/sdy32180","doi":"https://doi.org/10.25251/sdy32180","is_oa":true,"landing_page_url":"https://doi.org/10.25251/sdy32180","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/sdy32180","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112094786","display_name":"Mark G. Lebwohl","orcid":"https://orcid.org/0000-0002-4705-5303","observed_orcids":["https://orcid.org/0000-0002-4705-5303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark G. Lebwohl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025634637","display_name":"Raj Chovatiya","orcid":"https://orcid.org/0000-0001-6510-399X","observed_orcids":["https://orcid.org/0000-0001-6510-399X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raj Chovatiya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103088881","display_name":"Laura Korb Ferris","orcid":"https://orcid.org/0000-0002-0598-5182","observed_orcids":["https://orcid.org/0000-0002-0598-5182","https://orcid.org/0000-0003-3000-2165"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura K. Ferris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021721390","display_name":"Brent E. Mancha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brent E. Mancha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005456007","display_name":"Ikenna F. Unigwe","orcid":"https://orcid.org/0000-0001-8238-6901","observed_orcids":["https://orcid.org/0000-0001-8238-6901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ikenna Unigwe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108346061","display_name":"Nichiren Pillai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nichiren Pillai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117768100","display_name":"Bhargav Lakshminarasimhan","orcid":"https://orcid.org/0009-0006-2263-1366","observed_orcids":["https://orcid.org/0009-0006-2263-1366"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bhargav Lakshminarasimhan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043912373","display_name":"Jason R. Guercio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Guercio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034562654","display_name":"Mona Nili","orcid":"https://orcid.org/0000-0003-0513-2064","observed_orcids":["https://orcid.org/0000-0003-0513-2064"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mona Nili","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101062416","display_name":"Saraswati Agarwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saraswati Agarwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049859852","display_name":"Alice Bendix Gottlieb","orcid":"https://orcid.org/0000-0002-2927-8618","observed_orcids":["https://orcid.org/0000-0002-2927-8618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice B. Gottlieb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s854","last_page":"s854"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.887499988079071},{"id":"https://openalex.org/C2776907424","wikidata":"https://www.wikidata.org/wiki/Q5532501","display_name":"Generalized pustular psoriasis","level":3,"score":0.7282999753952026},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5885000228881836},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.5879999995231628},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.5680999755859375},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.49459999799728394},{"id":"https://openalex.org/C3019952477","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Health records","level":3,"score":0.4724999964237213},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4618000090122223},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4510999917984009},{"id":"https://openalex.org/C53084192","wikidata":"https://www.wikidata.org/wiki/Q1485121","display_name":"Gee","level":3,"score":0.4221999943256378},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.39739999175071716},{"id":"https://openalex.org/C534262118","wikidata":"https://www.wikidata.org/wiki/Q177719","display_name":"Medical diagnosis","level":2,"score":0.3637000024318695},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.35190001130104065},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34119999408721924},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33090001344680786},{"id":"https://openalex.org/C27403532","wikidata":"https://www.wikidata.org/wiki/Q5532474","display_name":"Generalized estimating equation","level":2,"score":0.3264000117778778},{"id":"https://openalex.org/C3020604521","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Plaque psoriasis","level":3,"score":0.32429999113082886},{"id":"https://openalex.org/C45827449","wikidata":"https://www.wikidata.org/wiki/Q5270338","display_name":"Diagnosis code","level":3,"score":0.3215999901294708},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3160000145435333},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.3118000030517578},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.28700000047683716},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.28619998693466187},{"id":"https://openalex.org/C39896193","wikidata":"https://www.wikidata.org/wiki/Q380344","display_name":"Descriptive statistics","level":2,"score":0.28380000591278076},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.27379998564720154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2694999873638153},{"id":"https://openalex.org/C2779911711","wikidata":"https://www.wikidata.org/wiki/Q30314007","display_name":"Pustular psoriasis","level":3,"score":0.25690001249313354},{"id":"https://openalex.org/C2780600951","wikidata":"https://www.wikidata.org/wiki/Q383126","display_name":"Chronic condition","level":3,"score":0.2535000145435333},{"id":"https://openalex.org/C2778959093","wikidata":"https://www.wikidata.org/wiki/Q5282128","display_name":"Disease registry","level":3,"score":0.25209999084472656}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/sdy32180","doi":"https://doi.org/10.25251/sdy32180","is_oa":true,"landing_page_url":"https://doi.org/10.25251/sdy32180","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/sdy32180","doi":"https://doi.org/10.25251/sdy32180","is_oa":true,"landing_page_url":"https://doi.org/10.25251/sdy32180","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W4205898093","https://openalex.org/W4401224584","https://openalex.org/W4407079627"],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Generalized":[1],"pustular":[2],"psoriasis":[3,44],"(GPP)":[4],"is":[5,47,61,76,98],"a":[6,48,250],"chronic":[7],"autoinflammatory":[8],"skin":[9],"disease":[10,51,187,193,298,452],"characterized":[11],"by":[12,28,54,429],"unpredictable":[13],"and":[14,21,75,82,114,161,173,186,191,214,246,267,293,322,337,343,352,372,397,415,435,438,466],"potentially":[15],"life-threatening":[16],"flares":[17],"of":[18,94,231,253,261,317,332,334,355,382,392,402,432,443,446,475],"widespread":[19],"erythema":[20],"sterile":[22],"pustules":[23],"that":[24,401,469],"may":[25,40,470],"be":[26],"accompanied":[27],"systemic":[29],"inflammation,":[30],"as":[31,33],"well":[32],"persistent":[34,422],"symptoms":[35],"between":[36],"flares.":[37],"Although":[38],"GPP":[39,97,120,143,171,192,235,303,313,426],"co-occur":[41],"with":[42,64,96,119,234,249,282,328],"plaque":[43,59,265],"(PsO),":[45],"it":[46],"distinct":[49],"clinical":[50,467],"driven":[52],"predominantly":[53],"IL-36":[55,73],"pathway":[56,74],"dysregulation,":[57],"whereas":[58],"PsO":[60,266],"primarily":[62],"associated":[63],"the":[65,72,78,92,122,133,178,198,203,239,268,302,308,359,377,440,473],"IL-23/IL-17":[66],"inflammatory":[67],"pathways.":[68],"Spesolimab":[69],"specifically":[70],"targets":[71],"currently":[77,99],"only":[79],"US":[80],"Food":[81],"Drug":[83],"Administration":[84],"(FDA)-approved":[85],"treatment":[86,93,115,185,464],"for":[87],"GPP.":[88],"Real-world":[89],"data":[90,131,166,183,208],"detailing":[91],"patients":[95,118,233,242,262,274,281,318],"limited.":[100],"To":[101],"address":[102],"this":[103,155,226],"gap,":[104],"we":[105],"describe":[106],"patient":[107,182],"characteristics,":[108],"health":[109],"care":[110],"resource":[111],"utilization":[112,391],"(HCRU),":[113],"patterns":[116,465],"among":[117,138,273],"in":[121,154,202,225,238,349,425,463],"US.":[123],"Methods:":[124],"This":[125],"observational":[126],"cohort":[127],"study":[128],"analyzed":[129],"retrospective":[130],"from":[132,145,197,472],"OM1":[134],"Real-World":[135],"Data":[136],"Cloud":[137],"individuals":[139],"who":[140],"had":[141,263,287,296],"\u22651":[142,174,215],"diagnosis":[144,172,213],"January":[146],"1,":[147],"2013":[148],"to":[149,387,450,459],"September":[150,388],"13,":[151],"2024.":[152],"Inclusion":[153,201],"analysis":[156,206],"required":[157,207],"linked":[158],"medical":[159,163],"claims":[160],"electronic":[162],"records":[164],"(EMR)":[165],"within":[167,209],"180":[168],"days":[169],"following":[170,212,379],"healthcare":[175,216],"encounter":[176,217],"beyond":[177,218],"180-day":[179],"period.":[180],"Individual":[181],"including":[184,406],"history,":[188],"laboratory":[189],"results,":[190],"characteristics":[194],"were":[195,223,236,243,365],"collected":[196],"EMR":[199],"data.":[200],"annual":[204],"HCRU":[205],"12":[210,219],"months":[211],"months.":[220],"Descriptive":[221],"statistics":[222],"used":[224,362],"study.":[227,240],"Results:":[228],"A":[229],"total":[230],"10,313":[232],"included":[237],"Most":[241],"female":[244],"(64.6%)":[245],"White":[247],"(87.5%),":[248],"mean":[251,269],"age":[252],"55.3":[254],"(SD:":[255,278],"18.0)":[256],"years.":[257],"Approximately":[258],"one-third":[259],"(31.9%)":[260],"comorbid":[264],"Charlson":[270],"Comorbidity":[271],"Index":[272],"(n=10,304)":[275],"was":[276,398],"1.4":[277],"2.0).":[279],"Among":[280],"available":[283],"assessments,":[284],"21.5%":[285],"(185/859)":[286],"\u226520%":[288],"affected":[289],"body":[290],"surface":[291],"area,":[292],"41.3%":[294],"(33/80)":[295],"moderate-to-severe":[297],"severity":[299],"based":[300],"on":[301],"Physician":[304],"Global":[305],"Assessment.":[306],"During":[307,376],"12-month":[309],"follow-up":[310],"period":[311,378],"after":[312],"diagnosis,":[314],"12.4%":[315],"(1,244/10,026)":[316],"experienced":[319,325],"all-cause":[320],"hospitalization,":[321,327],"1.2%":[323],"(119/10,026)":[324],"GPP-related":[326,344,363],"median":[329],"(IQR)":[330],"lengths":[331],"stay":[333],"6.0":[335],"(3.0-12.0)":[336],"5.0":[338],"(4.0-9.5)":[339],"days,":[340],"respectively.":[341,357],"All-cause":[342],"emergency":[345],"department":[346],"visits":[347],"occurred":[348],"21.3%":[350],"(2,132/10,026)":[351],"1.6%":[353],"(162/10,026)":[354],"patients,":[356],"Overall,":[358],"most":[360],"commonly":[361],"treatments":[364,449],"topical":[366],"corticosteroids":[367,370],"(40.2%),":[368],"oral":[369],"(13.6%),":[371],"non-GPP\u2013specific":[373],"biologics":[374],"(13.2%).":[375],"FDA":[380],"approval":[381],"intravenous":[383],"spesolimab":[384,393],"(September":[385],"2022":[386],"2024;":[389],"n=566),":[390],"remained":[394],"limited":[395],"(1.9%)":[396],"lower":[399],"than":[400],"several":[403],"non-GPP\u2012specific":[404,433],"biologics,":[405],"secukinumab":[407],"(5.7%),":[408],"risankizumab":[409],"(4.2%),":[410],"adalimumab":[411],"(3.5%),":[412],"infliximab":[413],"(2.5%),":[414],"guselkumab":[416],"(2.3%).":[417],"Conclusion:":[418],"These":[419],"findings":[420],"suggest":[421],"unmet":[423],"needs":[424],"management,":[427],"reflected":[428],"continued":[430],"use":[431],"therapies":[434],"high":[436],"HCRU,":[437],"highlight":[439],"potential":[441],"value":[442],"broader":[444],"adoption":[445],"targeted,":[447],"GPP-specific":[448,476],"reduce":[451],"burden.":[453],"Future":[454],"real-world":[455],"studies":[456],"are":[457],"needed":[458],"examine":[460],"long-term":[461],"shifts":[462],"outcomes":[468],"emerge":[471],"introduction":[474],"therapies.":[477]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}